Effect of gender on prevalence of irritable bowel syndrome in the community: systematic review and meta-analysis (Q38011936)

27 August 2017

0 references

Effect of gender on prevalence of irritable bowel syndrome in the community: systematic review and meta-analysis (English)

1 reference

27 August 2017

0 references

1 reference

irritable bowel syndrome

1 reference

2

1 reference

27 August 2017

Rebecca M Lovell

1

1 reference

27 August 2017

language of work or name

English

0 references

publication date

22 May 2012

1 reference

The American Journal of Gastroenterology

27 August 2017

published in

1 reference

27 August 2017

volume

107

1 reference

27 August 2017

issue

7

1 reference

27 August 2017

page(s)

991-1000

1 reference

U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.131

Functional gastrointestinal disorders in Canada: first population-based survey using Rome II criteria with suggestions for improving the questionnaire

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.131

Irritable bowel syndrome: a 10-yr natural history of symptoms and factors that influence consultation behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.131

Heightened visceral sensation in functional gastrointestinal disease is not site-specific. Evidence for a generalized disorder of gut sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.131

Quantitative meta-analysis identifies brain regions activated during rectal distension in irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.131

The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.131

The menstrual cycle affects rectal sensitivity in patients with irritable bowel syndrome but not healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.131

Mood changes and physical complaints during the normal menstrual cycle in healthy young women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.131

Meta-analysis: do irritable bowel syndrome symptoms vary between men and women?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.131

Towards positive diagnosis of the irritable bowel

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.131

Functional bowel disorders and functional abdominal pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.131

Functional bowel disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.131

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.131

Meta-analysis in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.131

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.131

Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.131

Irritable bowel syndrome according to varying diagnostic criteria: are the new Rome II criteria unnecessarily restrictive for research and practice?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.131

Epidemiological features of irritable bowel syndrome in a Turkish urban society

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.131

Gallstones, cholecystectomy and irritable bowel syndrome (IBS) MICOL population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.131

The prevalence, symptom characteristics, and impact of irritable bowel syndrome in an asian urban community

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.131

Prevalence of irritable bowel syndrome in Korea: population-based survey using the Rome II criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.131

Prevalence of irritable bowel syndrome according to different diagnostic criteria in a non-selected adult population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.131

A population-based study of irritable bowel syndrome in a non-Western population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.131

Chronic gastrointestinal symptoms and quality of life in the Korean population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.131

Irritable bowel syndrome in the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.131

Irritable bowel syndrome, gastro-oesophageal reflux, and bronchial hyper-responsiveness in the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.131

Prevalence of irritable bowel syndrome in Hong Kong

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.131

Epidemiology of irritable bowel syndrome in Chinese

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.131

Irritable bowel syndrome is strongly associated with generalized anxiety disorder: a community study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.131

Irritable Bowel Syndrome and Health-Related Quality of Life: A Population-Based Study in Calgary, Alberta

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.131

Irritable bowel syndrome in a rural community in Bangladesh: prevalence, symptoms pattern, and health care seeking behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.131

Irritable bowel syndrome prevalence varies enormously depending on the employed diagnostic criteria: comparison of Rome II versus previous criteria in a general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.131

A population study on irritable bowel syndrome and mental health

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.131

Prevalence and impact of upper and lower gastrointestinal symptoms in the Greek urban general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.131

Irritable bowel syndrome in a Bangladeshi urban community: prevalence and health care seeking pattern

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.131

A comparison of the Rome and Manning criteria for case identification in epidemiological investigations of irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.131

Prevalence of irritable bowel syndrome in a Brazilian Amazon community

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.131

A comparative reappraisal of the Rome II and Rome III diagnostic criteria: are we getting closer to the 'true' prevalence of irritable bowel syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.131

Irritable bowel syndrome in a community: symptom subgroups, risk factors, and health care utilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.131

Is the association between irritable bowel syndrome and abuse explained by neuroticism? A population based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.131

Prevalence of irritable bowel syndrome in Italian rural and urban areas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.131

Learned illness behavior in patients with irritable bowel syndrome and peptic ulcer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.131

A population-based epidemiologic study of irritable bowel syndrome in South China: stratified randomized study by cluster sampling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.131

The epidemiological aspects of irritable bowel syndrome in Southeastern Anatolia: a stratified randomised community-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.131

The epidemiology of chronic syndromes that are frequently unexplained: do they have common associated factors?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.131

Functional bowel symptoms in a general Dutch population and associations with common stimulants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.131

Prevalence and demographics of irritable bowel syndrome: results from a large web-based survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.131

Prevalence of, and risk factors for, chronic idiopathic constipation in the community: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.131

Meta-analysis: the epidemiology of noncardiac chest pain in the community

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.131

Systematic review: the influence of geography and ethnicity in irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.131

Bowel habit subtypes and temporal patterns in irritable bowel syndrome: systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.131

Efficacy and safety of alosetron in women with irritable bowel syndrome: a randomised, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.131

A randomized controlled clinical trial of the serotonin type 3 receptor antagonist alosetron in women with diarrhea-predominant irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.131

A randomized, double-blind, placebo-controlled study to assess efficacy and safety of 0.5 mg and 1 mg alosetron in women with severe diarrhea-predominant IBS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.131

Long-term safety and efficacy of alosetron in women with severe diarrhea-predominant irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.131

21 January 2018

Identifiers

DOI

10.1038/AJG.2012.131

1 reference

Dimensions Publication ID

27 August 2017

1050504896

0 references

1 reference